Japan Specialist

Mark Chadwick

Equity Bottom-Up

Pharma Foods International / Equity Bottom-Up

<ul>
<li>Pharma Foods has enjoyed 45% compound annual sales growth over the past five years. </li>
<li>This fiscal year, the company is guiding for sales to grow 160% to ¥40bn. </li>
<li>Growth is being driven by, Newmo, a hair growth product.</li>
<li>Longer-term, the tie-up with Mitsubishi Tanabe highlights the potential of the bio-tech pipeline. </li>
<li>TSE First Section inclusion and the stand-out growth metrics could see the stock attract a more institutional following.</li>
</ul>


Pharma Foods has enjoyed 45% compound annual sales growth over the past five years. 
This fiscal year, the company is guiding for sales to grow 160% to ¥40bn. 
Growth is being driven by, Newmo, a hair growth product.
Longer-term, the tie-up with Mitsubishi Tanabe highlights the potential of the bio-tech pipeline. 
TSE First Section inclusion and the stand-out growth metrics could see the stock attract a more institutional following.


Japan Small Cap Growth: Pharma Foods - Hair Growth = Stock Growth

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

Pharma Foods International / Event-Driven

<a href="https://www.smartkarma.com/entities/pharma-foods-international" target="_blank" data-smartkarma-citation="entities:10530:1" rel="noopener">Pharma Foods International (2929 JP)</a> as a biotech company is just over 20 years old. They develop and sell functional food ingredients, and according to a sponsored article they published in Newsweek last year, their three major areas of R&amp;D are immunity, ageing, and the nervous system. Functional food ingredients are ones where the chemical comes from a food, but where the chemical is then applied in more condensed use for a non-calorific pharmaceutical or nutraceutical product. Products include Pharma-GABA (Gamma-aminobutyric acid - an amino acid naturally contained in veg and fruit, created by fermented lactic acid bacteria), Bonepep, Ovopron (egg yolk globulin), Delicious Catechin (a chemical in green tea), RunPep (a peptide used in sports nutrition which is the result of hydrolizing egg white with enzymes), and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Apart from eggs, they use bananas, rice, sesame seeds, and green tea.The <a href="https://www.pharmafoods.co.jp/uploaded/files/e64847c232c753f6898b129e045b6b08c248c96d.pdf" target="_blank" rel="noopener">advertorial in Newsweek</a> quoted the President of PFI, Dr Mujo KIM, as saying that they hoped to reach ¥30bn of sales by 2025 and ¥50bn of sales by 2030 (the functional food business globally is growing at high single digits and is expected to be $275bn globally in 2025). And PFI just <a href="https://www.pharmafoods.co.jp/irlib/20210126_6c8209469200e6a9954f84da1858ae47.pdf" target="_blank" rel="noopener">signed a deal with Mitsubishi Tanabe Pharma</a> last week for development of a candidate antibody to target autoimmune disease.Since 2014, they have an online sales business, selling branded products under the "Tamagokichi" brand. They sell supplements and cosmetics using the same biotech functional food ingredients. Sales growth has been VERY strong recently. It is, in that sense If revenue in Q2-Q4 matches that of Q1, they will reach their 2030 revenue target this fiscal year (to July 2021). <h2>The NEW News</h2>Today they announced that the TSE had approved them to move to the TSE First Section on 12 February. Regular readers know what that means - a TOPIX inclusion!

Pharma Foods International (2929 JP) as a biotech company is just over 20 years old. They develop and sell functional food ingredients, and according to a sponsored article they published in Newsweek last year, their three major areas of R&amp;D are immunity, ageing, and the nervous system. Functional food ingredients are ones where the chemical comes from a food, but where the chemical is then applied in more condensed use for a non-calorific pharmaceutical or nutraceutical product. Products include Pharma-GABA (Gamma-aminobutyric acid - an amino acid naturally contained in veg and fruit, created by fermented lactic acid bacteria), Bonepep, Ovopron (egg yolk globulin), Delicious Catechin (a chemical in green tea), RunPep (a peptide used in sports nutrition which is the result of hydrolizing egg white with enzymes), and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Apart from eggs, they use bananas, rice, sesame seeds, and green tea.The advertorial in Newsweek quoted the President of PFI, Dr Mujo KIM, as saying that they hoped to reach ¥30bn of sales by 2025 and ¥50bn of sales by 2030 (the functional food business globally is growing at high single digits and is expected to be $275bn globally in 2025). And PFI just signed a deal with Mitsubishi Tanabe Pharma last week for development of a candidate antibody to target autoimmune disease.Since 2014, they have an online sales business, selling branded products under the "Tamagokichi" brand. They sell supplements and cosmetics using the same biotech functional food ingredients. Sales growth has been VERY strong recently. It is, in that sense If revenue in Q2-Q4 matches that of Q1, they will reach their 2030 revenue target this fiscal year (to July 2021). The NEW NewsToday they announced that the TSE had approved them to move to the TSE First Section on 12 February. Regular readers know what that means - a TOPIX inclusion!

TOPIX Inclusion: Pharma Foods Int'l (2929 JP) - Stupendous Revenue Growth Vs Ridiculous Volume/Float

Japan

Pharma Foods International Co.,Ltd. produces and sells bioengineered foods for commercial use.  The Company researches and develops physiologically functional foods.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pharma Foods International (2929 JP)

Japan Small Cap Growth: Pharma Foods - Hair Growth = Stock Growth

Pharma Foods has enjoyed 45% compound annual sales growth over the past five years and this year growth is expected to exceed 160%. Key driver is...

Mark Chadwick

TOPIX Inclusion: Pharma Foods Int'l (2929 JP) - Stupendous Revenue Growth Vs Ridiculous Volume/Float

Pharma Foods Intl is a biotech firm studying/producing high-tech supplement materials from basic foods. 95% of revenues come from its own exploding...

Travis Lundy

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)